Log in
Enquire now
‌

US Patent 10543271 Mesothelin binding proteins

Patent 10543271 was granted and assigned to Harpoon Therapeutics on January, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Harpoon Therapeutics
Harpoon Therapeutics
Current Assignee
Harpoon Therapeutics
Harpoon Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10543271
Patent Inventor Names
Richard J. Austin0
Bryan D. Lemon0
Holger Wesche0
Robert B. Dubridge0
Date of Patent
January 28, 2020
Patent Application Number
15977968
Date Filed
May 11, 2018
Patent Citations Received
‌
US Patent 11623958 Single chain variable fragment CD3 binding proteins
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
‌
US Patent 11607453 Mesothelin binding proteins
0
Patent Primary Examiner
‌
Nelson B Moseley, II
Patent abstract

Disclosed herein are MSLN binding proteins with improved binding affinities and improved ability to mediate T cell dependent killing of cancer cells expressing mesothelin. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are further provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10543271 Mesothelin binding proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.